Multidrug resistant Acinetobacter baumannii: a descriptive study in a city hospital
- PMID: 20609238
- PMCID: PMC2909240
- DOI: 10.1186/1471-2334-10-196
Multidrug resistant Acinetobacter baumannii: a descriptive study in a city hospital
Abstract
Background: Multidrug resistant Acinetobacter baumannii, (MRAB) is an important cause of hospital acquired infection. The purpose of this study is to determine the risk factors for MRAB in a city hospital patient population.
Methods: This study is a retrospective review of a city hospital epidemiology data base and includes 247 isolates of Acinetobacter baumannii (AB) from 164 patients. Multidrug resistant Acinetobacter baumannii was defined as resistance to more than three classes of antibiotics. Using the non-MRAB isolates as the control group, the risk factors for the acquisition of MRAB were determined.
Results: Of the 247 AB isolates 72% (177) were multidrug resistant. Fifty-eight percent (143/247) of isolates were highly resistant (resistant to imipenem, amikacin, and ampicillin-sulbactam). Of the 37 patients who died with Acinetobacter colonization/infection, 32 (86%) patients had the organism recovered from the respiratory tract. The factors which were found to be significantly associated (p < or = 0.05) with multidrug resistance include the recovery of AB from multiple sites, mechanical ventilation, previous antibiotic exposure, and the presence of neurologic impairment. Multidrug resistant Acinetobacter was associated with significant mortality when compared with sensitive strains (p < or = 0.01). When surgical patients (N = 75) were considered separately, mechanical ventilation and multiple isolates remained the factors significantly associated with the development of multidrug resistant Acinetobacter. Among surgical patients 46/75 (61%) grew a multidrug resistant strain of AB and 37/75 (40%) were resistant to all commonly used antibiotics including aminoglycosides, cephalosporins, carbepenems, extended spectrum penicillins, and quinolones. Thirty-five percent of the surgical patients had AB cultured from multiple sites and 57% of the Acinetobacter isolates were associated with a co-infecting organism, usually a Staphylococcus or Pseudomonas. As in medical patients, the isolation of Acinetobacter from multiple sites and the need for mechanical ventilation were significantly associated with the development of MRAB.
Conclusions: The factors significantly associated with MRAB in both the general patient population and surgical patients were mechanical ventilation and the recovery of Acinetobacter from multiple anatomic sites. Previous antibiotic use and neurologic impairment were significant factors in medical patients. Colonization or infection with MRAB is associated with increased mortality.
Similar articles
-
Study on the resistant genes to carbapenems and epidemiological characterization of multidrug-resistant Acinetobacter baumannii isolates.Microb Drug Resist. 2013 Apr;19(2):117-23. doi: 10.1089/mdr.2012.0049. Epub 2012 Jul 30. Microb Drug Resist. 2013. PMID: 22845773
-
A prospective multicenter study on the evaluation of antimicrobial resistance and molecular epidemiology of multidrug-resistant Acinetobacter baumannii infections in intensive care units with clinical and environmental features.Ann Clin Microbiol Antimicrob. 2019 Jul 2;18(1):19. doi: 10.1186/s12941-019-0319-8. Ann Clin Microbiol Antimicrob. 2019. PMID: 31266519 Free PMC article.
-
A multi-center study on the risk factors of infection caused by multi-drug resistant Acinetobacter baumannii.BMC Infect Dis. 2018 Jan 5;18(1):11. doi: 10.1186/s12879-017-2932-5. BMC Infect Dis. 2018. PMID: 29304746 Free PMC article.
-
Confronting multidrug-resistant Acinetobacter baumannii: a review.Int J Antimicrob Agents. 2011 Feb;37(2):102-9. doi: 10.1016/j.ijantimicag.2010.10.014. Epub 2010 Dec 4. Int J Antimicrob Agents. 2011. PMID: 21130607 Review.
-
Acinetobacter baumannii: an emerging multidrug-resistant threat.Expert Rev Anti Infect Ther. 2008 Jun;6(3):309-25. doi: 10.1586/14787210.6.3.309. Expert Rev Anti Infect Ther. 2008. PMID: 18588496 Review.
Cited by
-
Inhibition of the Quorum Sensing System, Elastase Production and Biofilm Formation in Pseudomonas aeruginosa by Psammaplin A and Bisaprasin.Molecules. 2022 Mar 6;27(5):1721. doi: 10.3390/molecules27051721. Molecules. 2022. PMID: 35268822 Free PMC article.
-
Taxonomic and Functional Distribution of Bacterial Communities in Domestic and Hospital Wastewater System: Implications for Public and Environmental Health.Antibiotics (Basel). 2021 Sep 1;10(9):1059. doi: 10.3390/antibiotics10091059. Antibiotics (Basel). 2021. PMID: 34572642 Free PMC article.
-
Disruption of tetR type regulator adeN by mobile genetic element confers elevated virulence in Acinetobacter baumannii.Virulence. 2017 Oct 3;8(7):1316-1334. doi: 10.1080/21505594.2017.1322240. Epub 2017 Apr 24. Virulence. 2017. PMID: 28436748 Free PMC article.
-
Alteration of the Gut Microbiota in Missed Abortion.Indian J Microbiol. 2023 Mar;63(1):106-119. doi: 10.1007/s12088-023-01063-y. Epub 2023 Feb 27. Indian J Microbiol. 2023. PMID: 37179577 Free PMC article.
-
Bacterial distribution on the ocular surface of patients with primary Sjögren's syndrome.Sci Rep. 2022 Feb 2;12(1):1715. doi: 10.1038/s41598-022-05625-w. Sci Rep. 2022. PMID: 35110614 Free PMC article.
References
-
- García-Garmendia JL, Ortiz-Leyba C, Garnacho-Montero J, Jiménez-Jiménez FJ, Monterrubio-Villar J, Gili-Miner M. Mortality and the increase in length of stay attributable to the acquisition of Acinetobacter in critically ill patients. Crit Care Med. 1999;27(9):1794–1799. doi: 10.1097/00003246-199909000-00015. - DOI - PubMed
-
- Jamulitrat S, Arunpan P, Phainuphong P. Attributable mortality of imipenem-resistant nosocomial Acinetobacter baumannii bloodstream infection. J Med Assoc Thai. 2009;92(3):413–419. - PubMed
-
- Falagas ME, Koletsi PK, Bliziotis IA. The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. J Med Microbiol. 2006;55(Pt 12):1615–1617. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials